Interferon therapy for chronic type B hepatitis: the promise comes of age.
Perrillo
R P
RP
Washington University, School of Medicine, St. Louis, Missouri.
D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004279:DNA, Viral / Q000032:analysis; D005544:Forecasting; D005762:Gastroenterology / Q000639:trends*; D006509:Hepatitis B / Q000201:enzymology / Q000276:immunology / Q000628:therapy*; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012107:Research Design; D000637:Transaminases / Q000378:metabolism
D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D007372:Interferons; D000637:Transaminases